Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Not Confirmed
Not Confirmed
03-05 April, 2025
Not Confirmed
Not Confirmed
05-09 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Industry Trade Show
Not Confirmed
03-05 April, 2025
Industry Trade Show
Not Confirmed
05-09 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
10 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/10/3023315/0/en/RespireRx-Pharmaceuticals-Inc-CFO-and-CEO-Issue-Letter-to-Stockholders-Stakeholders-Strategic-and-Potential-Strategic-Partners-and-Other-Interested-Parties.html
29 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/29/2889855/0/en/RespireRx-Pharmaceuticals-Inc-Announces-a-Department-of-Defense-Award-to-Fund-a-Phase-2-Clinical-Study-to-Determine-the-Safety-and-Efficacy-of-CX1739-its-Lead-AMPAkine-to-Improve-B.html
20 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/20/2849358/0/en/RespireRx-Pharmaceuticals-Inc-Reports-Publication-of-Preclinical-Research-Results-Demonstrating-the-Ability-of-CX1739-its-Lead-Clinical-AMPAkine-to-Improve-Bladder-Function-After-S.html
13 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/13/2828252/0/en/RespireRx-Pharmaceuticals-Inc-Reports-Preclinical-Pain-Relief-for-their-Non-Opioid-Lead-GABAkine.html
22 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/01/22/2813052/0/en/RespireRx-Pharmaceuticals-Inc-Announces-the-Appointment-of-Dr-Dariusz-Naziek-to-Its-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/01/04/2804014/0/en/RespireRx-Pharmaceuticals-Inc-Announces-the-Publication-of-a-Case-Report-in-which-KRM-II-81-Totally-Suppressed-Epileptiform-Activity-in-Brain-Tissue-Surgically-Removed-from-Epilept.html
ABOUT THIS PAGE
RespireRx Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of AMPALEX, BULK PHARMACEUTICAL CHEMICAL (BPC) bulk offered by RespireRx Pharmaceuticals